Table 2. Summary of Association with the Risk of PAD.

dbSNP ID	Chr.	Gene	Phase	Number of samples		MAF		OR	95%CI	P
				Cases	Controls	Cases	Controls
rs9584669	13	IPO5/RAP2A	GWAS	785	3383	0.04	0.06	0.60	0.45–0.79	2.76 x 10−4
			Replication	2379	16751	0.03	0.05	0.57	0.48–0.66	2.10 x 10−11
			Combined*	3164	20134	0.03	0.05	0.58	0.50–0.66	6.78 x 10−14
rs6842241	4	EDNRA	GWAS	785	3372	0.36	0.30	0.76	0.68–0.85	2.36 x 10−6
			Replication	2342	16750	0.33	0.30	0.88	0.83–0.93	9.09 x 10−5
			Combined*	3127	20122	0.34	0.30	0.85	0.80–0.90	5.32 x 10−9
rs2074633	7	HDAC9	GWAS	785	3382	0.43	0.38	1.24	1.11–1.38	1.41 x 10−4
			Replication	2363	16751	0.41	0.38	1.13	1.06–1.20	7.63 x 10−5
			Combined*	3148	20133	0.41	0.38	1.16	1.10–1.22	8.43x 10−8

ID; identifier, Chr.; chromosome, MAF; minor allele frequency, OR; odds ratio, CI; confidence interval.

*; P value was calculated by Mantel-Haenszel test.